Home/Filings/4/0000950170-25-007557
4//SEC Filing

Duarte Ira 4

Accession 0000950170-25-007557

CIK 0000818033other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:32 AM ET

Size

7.2 KB

Accession

0000950170-25-007557

Insider Transaction Report

Form 4
Period: 2025-01-19
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-193,87446,492 total
    Exercise: $0.00Common Stock (3,874 underlying)
  • Exercise/Conversion

    Common Stock

    2025-01-19+3,874120,580 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Includes 8,705 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2024.
  • [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001488864

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 9:32 AM ET
Size
7.2 KB